|
NCAPD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.70190528336889E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.74260000002291E-06 |
| Normal-vs-Stage2 |
1.202110E-02 |
| Normal-vs-Stage3 |
3.649100E-04 |
| Normal-vs-Stage4 |
1.123630E-02 |
| Stage1-vs-Stage2 |
9.081800E-01 |
| Stage1-vs-Stage3 |
3.664000E-02 |
| Stage1-vs-Stage4 |
1.420990E-01 |
| Stage2-vs-Stage3 |
1.809980E-01 |
| Stage2-vs-Stage4 |
2.008600E-01 |
| Stage3-vs-Stage4 |
9.727600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.44639991492579E-10 |
| Normal-vs-AfricanAmerican |
6.17760000000134E-05 |
| Normal-vs-Asian |
2.057600E-01 |
| Caucasian-vs-AfricanAmerican |
6.208400E-01 |
| Caucasian-vs-Asian |
8.436400E-01 |
| AfricanAmerican-vs-Asian |
9.766200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.74560002195324E-09 |
| Normal-vs-Female |
7.08920000480617E-09 |
| Male-vs-Female |
1.354060E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.696240E-03 |
| Normal-vs-Extreme_Weight |
7.168700E-04 |
| Normal-vs-Obese |
8.82570000415583E-08 |
| Normal-vs-Extreme_Obese |
5.755000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.238200E-01 |
| Normal_Weight-vs-Obese |
1.086240E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.444600E-01 |
| Extreme_Weight-vs-Obese |
1.546470E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.524800E-01 |
| Obese-vs-Extreme_Obese |
4.327800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.58671999999083E-05 |
| Normal-vs-Age(41-60Yrs) |
2.74119615895074E-11 |
| Normal-vs-Age(61-80Yrs) |
5.55369999999389E-05 |
| Normal-vs-Age(81-100Yrs) |
2.662400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.936600E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.950500E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.018810E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.009590E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.785500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.288400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.01629848770335E-11 |
| Normal-VS-Type2 PRCC |
8.206300E-02 |
| Normal-VS-KIRP CIMP |
3.589900E-04 |
| Normal-VS-Unclassified PRCC |
6.22569999999545E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.772660E-04 |
| Type1 PRCC-VS-KIRP CIMP |
8.22660000010522E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
1.965230E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.626600E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.456340E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.584900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.234390E-02 |
| Normal-vs-N1 |
1.838770E-04 |
| Normal-vs-N2 |
3.942500E-02 |
| N0-vs-N1 |
4.882800E-03 |
| N0-vs-N2 |
9.297200E-03 |
| N1-vs-N2 |
7.469200E-01 |
|
|
